|
Head and Neck Cancer Research Studies
METASTATIC / RECURRENT
E1305 A Phase III
Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with
Recurrent or Metastatic Head and Neck Cancer
LOCALLY ADVANCED
R0920 Phase III Study of Postoperative Radiation Therapy (IMRT) +/-
Cetuximab for Locally Advanced Resected Head and Neck Cancer
OROPHARYNX
E1308 A Phase II Trial of Induction Chemotherapy Followed by
Cetuximab (Erbitux) with Low Dose vs. Standard Dose IMRT in Patients with HPV-Associated
Resectable Squamous Cell Carcinoma of the Oropharynx
|